Search - tctmd.com

Displaying 641 - 660 of 868

Sort: Relevancy | Date

Presentation TCT 2014

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

Presenter: Emmanouil S. Brilakis, J. Dawn Abbott

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Conference News TCT 2014

COMPARE II: BES, EES Show Similar Outcomes at Three Years

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News TCT 2013

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

November 03, 2013

Presentation TCT 2013

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Presenter: Gilles Montalescot

October 31, 2013

Presentation TCT 2013

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Presenter: Dariusz Dudek

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

Indigenous Stents: New Technologies and Clinical Data

Presenter: Sreenivas Kumar

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

Presentation TCT 2013

Case 4 : A Complex Bifurcation with Planned 2 Stents

Presenter: Alaide Chieffo

October 30, 2013

Presentation TCT 2013

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

Presenter: Michael Maeng

October 30, 2013

Presentation TCT 2013

Case #11: In the Future Bifurcation Stents Will Disappear!

Presenter: Evald Christiansen

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

Presentation TCT 2013

New Stents

Presenter: Sotirios Tsimikas

October 30, 2013

Advertisement

Bare Metal and Drug-Eluting Stents: Devices, Indications, and Outcomes

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

Misago BMS Performs Well in Multinational Trial of Patients with SFA Lesions

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

COMPARE II: BES, EES Show Similar Outcomes at Three Years

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Meta-analysis: Most DES Safer Than BMS, Biodegradability Offers No Extra Benefit

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Indigenous Stents: New Technologies and Clinical Data

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Case 4 : A Complex Bifurcation with Planned 2 Stents

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

Case #11: In the Future Bifurcation Stents Will Disappear!

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

New Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content